Kimchi-Sarfaty Chava, Alexander Nathan S, Brittain Scott, Ali Saadia, Gottesman Michael M
National Cancer Institute, NIH, Bethesda, MD 20892-4256, USA.
Biotechniques. 2004 Aug;37(2):270-5. doi: 10.2144/04372RR04.
This comprehensive study demonstrates highly efficient transduction of a wide variety of human, murine, and monkey cell lines, using a procedure for in vitro packaging of plasmid DNA in recombinant simian virus 40 (SV40) capsid proteins to form pseudovirions. The pseudovirions are encapsidated by the VP1 major capsid protein, with no SV40 sequence requirement, and are able to carry up to 17.7 kb of supercoiled plasmid DNA. We developed a procedure to scale-up production of SV40 pseudovirions, as well as an efficient protocol to concentrate the virions with no loss of activity. We also developed a method that allows transduction of 10 times more cells than the original protocol. This protocol was tested using supercoiled in vitro-packaged plasmid carrying the human multidrug-resistance gene (MDR1 encoding P-glycoprotein; P-gp), or the enhanced green fluorescent protein reporter gene (EGFP) in .45 human lymphoblastoid cells and in K562 human erythroleukemia cells. Multiple transductions at 24-h intervals were shown to increase expression using the EGFP reporter gene. The protocols developed in this study establish in vitro-packaged SV40 pseudovirions as one of the most efficient gene delivery systems.
这项综合性研究表明,利用一种在重组猿猴病毒40(SV40)衣壳蛋白中对质粒DNA进行体外包装以形成假病毒颗粒的程序,可高效转导多种人类、小鼠和猴子细胞系。这些假病毒颗粒由主要衣壳蛋白VP1包裹,无需SV40序列,并且能够携带长达17.7 kb的超螺旋质粒DNA。我们开发了一种扩大SV40假病毒颗粒生产规模的程序,以及一种高效浓缩病毒颗粒且不损失活性的方案。我们还开发了一种方法,该方法能够转导的细胞数量比原始方案多10倍。使用携带人类多药耐药基因(编码P-糖蛋白的MDR1;P-gp)的超螺旋体外包装质粒,或增强型绿色荧光蛋白报告基因(EGFP),在45个人类淋巴母细胞和K562人红白血病细胞中对该方案进行了测试。结果表明,使用EGFP报告基因时,以24小时间隔进行多次转导可增加表达。本研究中开发的方案将体外包装的SV40假病毒颗粒确立为最有效的基因递送系统之一。